Diabetes: We Care
A few years ago, Dr. Chen had the opportunity to share in the joys and sorrows of children afflicted with diabetes during an evening outing at a local summer camp. At the meeting, there were many heartfelt interactions between these children, their families, and Dr. Chen. What touched Dr. Chen the most, was when a small child, about 2-3 years old, who was diagnosed as type 1 diabetic, put her small hand in Dr. Chen’s hand and showed to Dr. Chen, the child’s painful daily experience to test her blood glucose. It was while holding the small hand of this child in Dr. Chen’s palm, that Dr. Chen felt that this was a turning point in her life. It was at that silent moment, that Dr. Chen realized her need to make a difference in the lives of these children, and for other patients with unmet needs. The image of this little girl was forever etched into Dr. Chen’s mind. It has become an everlasting source of strength to encourage ABS to move forward in haste to develop its revolutionary technologies and innovative medical devices for diabetes around the world.
ABS has developed nanostructured biomimetic reagent-less devices. They are able to mimic the function of Acetylcholinesterase (ACHE), through analyzing of the acetylcholine (ACH), Amyloid-beta and Slow Wave Sleep curves. We have found a common link that may be led to many diseases. ABS’s research and product development team will have four presentations in medical devices and in Energy-Sensory images at the Techconnect World Conference, June 14-17, 2015, www.techconnectworld.com.
ABS’s work in Biomimetic Sensing and Energy Storage, as a chapter was included in the collection of Dekker Encyclopedia of Nanoscience and Nanotechnology in the first volume, Third Edition, edited by Lyshevski SE, March 20, 2014 at www.crcpress.com.
The U.S. Patent Office issued the Notice of Allowance letters to the following titles of patent applications in 2016:
1. A Nanostructured Biomimetic Device for Detecting a Cancer cell or Cancer cells
2. Nanobiomimetic Supercapacitors with High Rate High Energy Storage
A patent # 8,632,925 was issued by the US Patent Office on January 21, 2014. A patent # 8,641,876 was issued on February 4, 2014.
National Innovation Showcase
ABS showcased its nanobiomimetic reagent-less platform technology at the Tech Connect World Conference in May 23-26, 2016 and June 14-17, 2015 at Washington DC.